Cellebrite DI Statistics
Total Valuation
Cellebrite DI has a market cap or net worth of $4.70 billion. The enterprise value is $4.19 billion.
Important Dates
The next confirmed earnings date is Wednesday, May 14, 2025, before market open.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Cellebrite DI has 239.47 million shares outstanding. The number of shares has increased by 10.16% in one year.
| Current Share Class | 239.47M |
| Shares Outstanding | 239.47M |
| Shares Change (YoY) | +10.16% |
| Shares Change (QoQ) | +18.52% |
| Owned by Insiders (%) | 2.71% |
| Owned by Institutions (%) | 38.10% |
| Float | 107.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 45.90 |
| PS Ratio | 10.21 |
| Forward PS | 9.44 |
| PB Ratio | 13.65 |
| P/TBV Ratio | 15.74 |
| P/FCF Ratio | 37.70 |
| P/OCF Ratio | 35.26 |
| PEG Ratio | 3.02 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 62.02, with an EV/FCF ratio of 33.88.
| EV / Earnings | n/a |
| EV / Sales | 10.44 |
| EV / EBITDA | 62.02 |
| EV / EBIT | 73.58 |
| EV / FCF | 33.88 |
Financial Position
The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.03.
| Current Ratio | 1.92 |
| Quick Ratio | 1.79 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.15 |
| Debt / FCF | 0.09 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -152.88% and return on invested capital (ROIC) is 17.99%.
| Return on Equity (ROE) | -152.88% |
| Return on Assets (ROA) | 5.81% |
| Return on Invested Capital (ROIC) | 17.99% |
| Return on Capital Employed (ROCE) | 14.40% |
| Revenue Per Employee | $343,790 |
| Profits Per Employee | -$242,508 |
| Employee Count | 1,167 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 6.63 |
Taxes
In the past 12 months, Cellebrite DI has paid $7.02 million in taxes.
| Income Tax | 7.02M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +80.77% in the last 52 weeks. The beta is 1.44, so Cellebrite DI's price volatility has been higher than the market average.
| Beta (5Y) | 1.44 |
| 52-Week Price Change | +80.77% |
| 50-Day Moving Average | 18.86 |
| 200-Day Moving Average | 18.56 |
| Relative Strength Index (RSI) | 52.92 |
| Average Volume (20 Days) | 954,759 |
Short Selling Information
The latest short interest is 1.49 million, so 0.62% of the outstanding shares have been sold short.
| Short Interest | 1.49M |
| Short Previous Month | 1.28M |
| Short % of Shares Out | 0.62% |
| Short % of Float | 1.39% |
| Short Ratio (days to cover) | 1.04 |
Income Statement
In the last 12 months, Cellebrite DI had revenue of $401.20 million and -$283.01 million in losses. Loss per share was -$1.35.
| Revenue | 401.20M |
| Gross Profit | 338.61M |
| Operating Income | 56.91M |
| Pretax Income | -106.25M |
| Net Income | -283.01M |
| EBITDA | 67.51M |
| EBIT | 56.91M |
| Loss Per Share | -$1.35 |
Full Income StatementBalance Sheet
The company has $447.22 million in cash and $10.97 million in debt, giving a net cash position of $472.86 million or $1.97 per share.
| Cash & Cash Equivalents | 447.22M |
| Total Debt | 10.97M |
| Net Cash | 472.86M |
| Net Cash Per Share | $1.97 |
| Equity (Book Value) | 336.02M |
| Book Value Per Share | 1.43 |
| Working Capital | 272.09M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $132.17 million and capital expenditures -$8.57 million, giving a free cash flow of $123.61 million.
| Operating Cash Flow | 132.17M |
| Capital Expenditures | -8.57M |
| Free Cash Flow | 123.61M |
| FCF Per Share | $0.52 |
Full Cash Flow StatementMargins
Gross margin is 84.40%, with operating and profit margins of 14.18% and -70.54%.
| Gross Margin | 84.40% |
| Operating Margin | 14.18% |
| Pretax Margin | -68.79% |
| Profit Margin | -70.54% |
| EBITDA Margin | 16.83% |
| EBIT Margin | 14.18% |
| FCF Margin | 30.81% |
Dividends & Yields
Cellebrite DI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.16% |
| Shareholder Yield | -10.16% |
| Earnings Yield | -6.07% |
| FCF Yield | 2.65% |
Dividend DetailsAnalyst Forecast
The average price target for Cellebrite DI is $23.43, which is 19.30% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $23.43 |
| Price Target Difference | 19.30% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 16.47% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cellebrite DI has an Altman Z-Score of 5.93 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.93 |
| Piotroski F-Score | 5 |